Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CMV IGG Antibodies in Semen as a Predictor for Blood Testis Barrier Damage

NCT05302856 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT05302856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05302856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CMV IGG Antibodies in Semen as a Predictor for Blood Testis Barrier Damage
Lead sponsor
Hadassah Medical Organization
Phase
Not applicable
Overall status
Unknown status
Start date
March 2, 2022
Completion date
March 31, 2023
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

male infertility